Cardiac transplantation in transthyretin amyloid cardiomyopathy: outcomes from three decades of tertiary centre experience

Back

ESC Professional Premium Access

Cardiac transplantation in transthyretin amyloid cardiomyopathy: outcomes from three decades of tertiary centre experience

Session: Cardiac amyloidosis

Topic: Infiltrative Myocardial Disease

Speaker: Doctor Y. Razvi (London, GB)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Yousuf Razvi

University College London, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

7 more presentations in this session

Multi-imaging characterisation of cardiac phenotype in different types of amyloidosis

Speaker: Doctor A. Ioannou (Greater London, GB)

Access

Abstract

Slides

Transthyretin amyloid cardiomyopathy: a 2-year single-centre experience

Speaker: Doctor B. Rocha (Lisbon, PT)

Access

Abstract

Slides

Two-dimensional speckle-tracking echocardiography in tafamidis-treated patients with transthyretin amyloid cardiomyopathy: a glimmer of hope for viable therapy monitoring?

Speaker: Doctor R. Rettl (Vienna, AT)

Access

Abstract

Slides

Cardiac amyloidosis is not a single disease: a multiparametric comparison between the light chain and transthyretin forms

Speaker: Doctor G. Neculae (Bucharest, RO)

Access

Abstract

Slides

Detection of arrhythmias in patients with cardiac amyloidosis using implantable ECG recorders.

Speaker: Professor M. Taborsky (Olomouc, CZ)

Access

Abstract

Slides

Access the full session

Cardiac amyloidosis

Speakers: Doctor Y. Razvi, Doctor A. Ioannou, Doctor B. Rocha, Doctor R. Rettl, Doctor G. Neculae...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources